Different doses of imeglimin for management of type 2 diabetes mellitus: a systematic review, meta-analysis, and meta-regression of randomized clinical trials
CONCLUSIONS: Our study suggests that imeglimin 1000 mg twice daily may offer the most optimum therapeutic effects for glycemic control without compromising its safety profiles.PMID:38047423 | DOI:10.1080/17446651.2023.2290488 (Source: Expert Review of Endocrinology and Metabolism)
Source: Expert Review of Endocrinology and Metabolism - December 4, 2023 Category: Endocrinology Authors: Hikmat Permana Nanny Natalia Mulyani Soetedjo Theo Audi Yanto Marshell Tendean Timotius Ivan Hariyanto Ketut Suastika Source Type: research

Clinical management of androgen excess and defect in women
Expert Rev Endocrinol Metab. 2023 Nov 12:1-15. doi: 10.1080/17446651.2023.2279537. Online ahead of print.ABSTRACTINTRODUCTION: Hyperandrogenism and hypoandrogenism are complex disorders involving multiple-organ systems. While androgen excess is a well-characterized condition, androgen deficiency still needs diagnostic criteria, as there are no specific cutoffs.AREAS COVERED: We highlight the most recent findings on the role of androgens in female pathophysiology, investigating clinically relevant conditions of androgen insufficiency or excess throughout a woman's life, and their possible therapeutic management.EXPERT OPINI...
Source: Expert Review of Endocrinology and Metabolism - November 13, 2023 Category: Endocrinology Authors: Elena Rosato Francesca Sciarra Marianna Minnetti Anisa Degjoni Mary Anna Venneri Source Type: research